Literature DB >> 9814465

Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.

B Bülow1, R Attewell, L Hagmar, P Malmström, C H Nordström, E M Erfurth.   

Abstract

Specific causes of death, survival, and recurrence rates were assessed in a cohort of 60 patients who had undergone surgery for craniopharyngioma between 1951 and 1988. Compared to the general population, the standardized mortality ratio (SMR) was increased [5.55; 95% confidence interval (CI), 3.68-8.22], and it was higher among females (SMR, 11.4) than males (SMR, 4.79). The risk of cardio- and cerebrovascular mortality (SMR, 3.21; 95% CI, 1.29-6.61) was also enhanced. The cumulative survival rates 10 and 15 yr after the initial operation were 68% (95% CI 54-78) and 59% (95% CI 30-63), respectively. A multivariate survival analysis adjusting for age showed a protective effect of radiotherapy (hazard ratio, 0.3; 95% CI, 0.1-0.8) and an increased risk of death after recurrence (hazard ratio, 4.4; 95% CI, 1.4-14), but no obvious effect of radicality at surgery. However, when patients who had died within 6 months after surgery were excluded, no significant protective effect of radiotherapy remained. The cumulative frequency of recurrence after 10 yr was 33% (95% CI, 22-48%), and that after 15 yr was 40% (95% CI, 28-56%). The incidence of recurrence did not differ significantly with respect to age, radicality at surgery, or postoperative radiotherapy. The determinants for long term outcome in patients with craniopharyngioma are interrelated in a complex way, which calls for strict selection criteria in follow-up studies and the use of multivariate statistical models.

Entities:  

Mesh:

Year:  1998        PMID: 9814465     DOI: 10.1210/jcem.83.11.5240

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.

Authors:  Jessica K Schefter; George Allen; Anthony J Cmelak; Mahlon Johnson; Steven Toms; Dennis Duggan; Lewis S Blevins
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

2.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

Review 3.  Surgical management of craniopharyngiomas.

Authors:  Ricardo J Komotar; Marie Roguski; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 4.  Excess mortality after craniopharyngioma treatment: are we making progress?

Authors:  Nidan Qiao
Journal:  Endocrine       Date:  2018-12-19       Impact factor: 3.633

5.  Ectopic recurrence of a craniopharyngioma in a 15-year-old girl 9 years after surgery and conventional radiotherapy: case report.

Authors:  Maria Elfving; Johan Lundgren; Elisabet Englund; Lars-Göran Strömblad; Eva-Marie Erfurth
Journal:  Childs Nerv Syst       Date:  2011-01-11       Impact factor: 1.475

Review 6.  A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors.

Authors:  Christopher S Graffeo; August R Dietrich; Bartosz Grobelny; Meng Zhang; Judith D Goldberg; John G Golfinos; Richard Lebowitz; David Kleinberg; Dimitris G Placantonakis
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 7.  Craniopharyngioma.

Authors:  Hermann L Müller; Thomas E Merchant; Monika Warmuth-Metz; Juan-Pedro Martinez-Barbera; Stephanie Puget
Journal:  Nat Rev Dis Primers       Date:  2019-11-07       Impact factor: 52.329

8.  Acute presentation of craniopharyngioma in children and adults in a Danish national cohort.

Authors:  E H Nielsen; J O Jørgensen; P Bjerre; M Andersen; C Andersen; U Feldt-Rasmussen; L Poulsgaard; L Ø Kristensen; J Astrup; J Jørgensen; P Laurberg
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

9.  A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity.

Authors:  Jefferson P Lomenick; Maciej S Buchowski; Ashley H Shoemaker
Journal:  Obesity (Silver Spring)       Date:  2016-05-02       Impact factor: 5.002

Review 10.  Mortality and morbidity in adult craniopharyngioma.

Authors:  Eva Marie Erfurth; Helene Holmer; Sigridur Bara Fjalldal
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.